Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 9, 2004
(February 9, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed its purchase of the Addition Hill Corporate Center in Marlborough, Massachusetts. The site...
-
Feb 6, 2004
(February 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that an inspection team from the U.S. Food and Drug Administration (FDA) has completed its inspection of the...
-
Feb 4, 2004
(February 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE registry program, which plans to enroll 2,000 patients at approximately 50...
-
Jan 30, 2004
(January 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that the United States District Court for the District of Delaware has scheduled a trial for June 2005 in the...
-
Jan 29, 2004
(January 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS™ Express2™...
-
Jan 28, 2004
(January 28, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2004 Merrill Lynch Pharmaceutical, Biotechnology and Medical Device Conference, which is being...
-
Jan 22, 2004
(January 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31, 2003 on Monday,...
-
Jan 21, 2004
(January 21, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2004 Piper Jaffray Health Care Conference, which is being held January 27-29 in New York City....
-
Jan 16, 2004
(January 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed enrollment of a clinical trial to evaluate the benefits of stenting - in conjunction with...
-
Jan 6, 2004
(January 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 22nd Annual JPMorgan Healthcare Conference, which is being held January 12-15 in San Francisco....